advertisement
Biogen Idec downgraded to "underperform"
10/21/09 - BMO Capital Markets
NEW YORK, October 21 (newratings.com) - Analysts at BMO Capital Markets downgrade Biogen Idec (BIIB) from "market perform" to "underperform."
News